NovaBay Pharmaceuticals, Inc. NBY 0.61 NovaBay Pharmaceuticals, Inc.

Home
  /  
Stock List  /  NovaBay Pharmaceuticals, Inc.
Range:0.36-13.3Vol Avg:2652143Last Div:0Changes:0.04
Beta:0.75Cap:0.00BCurrency:USDExchange:AMEX
Sector:HealthcareIPO:Fri Oct 26 2007Empoloyees:24
CUSIP:66987P201CIK:0001389545ISIN:US66987P3001Country:US
CEO:Mr. Justin M. Hall Esq.Website:https://novabay.com
NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, SPF, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand. It sells its products through retailers, digital beauty channels, and distributors, as well as online. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.

Stock Details

The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
DMCA.com Protection StatusPowered by StackThrow